CT-080 by First Condor Group for Esophageal Cancer: Likelihood of Approval

CT-080 is under clinical development by First Condor Group and currently in Phase II for Esophageal Cancer.

Oct 3, 2023 - 20:00
CT-080 is under clinical development by First Condor Group and currently in Phase II for Esophageal Cancer.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow